Skip to content
The Great News – Lifestyle
Home
Sample Page
Author:
Kither Biotech
Kither Biotech Initiates Dosing of Patients in Phase 1b / 2a Study of KIT2014 in COPD
September 29, 2026
Kither Biotech successfully completes Phase 1 clinical trial of KIT2014, a novel inhaled peptide therapy for respiratory diseases
June 19, 2026